Tree AC - Search Results

1

Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.

Brand DH, Brüningk SC, Wilkins A, Naismith O, Gao A, Syndikus I, Dearnaley DP, Hall E, van As N, Tree AC, Gulliford S. Brand DH, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1163-1173. doi: 10.1016/j.ijrobp.2023.07.002. Epub 2023 Jul 16. Int J Radiat Oncol Biol Phys. 2023. PMID: 37433374 Free PMC article.

2

Bone health and therapeutic agents in advanced prostate cancer.

Gómez-Aparicio MA, López-Campos F, Pelari-Mici L, Buchser D, Pastor J, Maldonado X, Zafra J, Tree AC, Bultijnck R, Sargos P, Ost P, Couñago F. Gómez-Aparicio MA, et al. Among authors: tree ac. Front Biosci (Landmark Ed). 2022 Jan 18;27(1):34. doi: 10.31083/j.fbl2701034. Front Biosci (Landmark Ed). 2022. PMID: 35090339 Free article. Review.

3

Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer.

de Muinck Keizer DM, Pathmanathan AU, Andreychenko A, Kerkmeijer LGW, van der Voort van Zyp JRN, Tree AC, van den Berg CAT, de Boer JCJ. de Muinck Keizer DM, et al. Among authors: tree ac. Phys Med Biol. 2019 Apr 4;64(7):07NT02. doi: 10.1088/1361-6560/ab09a6. Phys Med Biol. 2019. PMID: 30794995

4

Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?

Palma D, Tree A, Guckenberger M. Palma D, et al. Lancet Oncol. 2021 Aug;22(8):1067-1068. doi: 10.1016/S1470-2045(21)00203-5. Lancet Oncol. 2021. PMID: 34339642 No abstract available.

5

Stereotactic body radiotherapy for oligometastases.

Tree AC, Khoo VS, Eeles RA, Ahmed M, Dearnaley DP, Hawkins MA, Huddart RA, Nutting CM, Ostler PJ, van As NJ. Tree AC, et al. Lancet Oncol. 2013 Jan;14(1):e28-37. doi: 10.1016/S1470-2045(12)70510-7. Lancet Oncol. 2013. PMID: 23276369 Review.

6

Biological dose escalation and hypofractionation: what is there to be gained and how will it best be done?

Tree AC, Alexander EJ, Van As NJ, Dearnaley DP, Khoo V. Tree AC, et al. Clin Oncol (R Coll Radiol). 2013 Aug;25(8):483-98. doi: 10.1016/j.clon.2013.05.003. Epub 2013 Jun 27. Clin Oncol (R Coll Radiol). 2013. PMID: 23810749 Review.

7

Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?

Tree A, Jones C, Sohaib A, Khoo V, van As N. Tree A, et al. Radiat Oncol. 2013 Oct 2;8:228. doi: 10.1186/1748-717X-8-228. Radiat Oncol. 2013. PMID: 24088319 Free PMC article.

8

New horizons and hurdles for UK radiotherapy: can prostate stereotactic body radiotherapy show the way?

Tree A, Ostler P, van As N. Tree A, et al. Clin Oncol (R Coll Radiol). 2014 Jan;26(1):1-3. doi: 10.1016/j.clon.2013.11.002. Epub 2013 Dec 2. Clin Oncol (R Coll Radiol). 2014. PMID: 24296326 No abstract available.

9

Is biochemical relapse-free survival after profoundly hypofractionated radiotherapy consistent with current radiobiological models?

Tree AC, Khoo VS, van As NJ, Partridge M. Tree AC, et al. Clin Oncol (R Coll Radiol). 2014 Apr;26(4):216-29. doi: 10.1016/j.clon.2014.01.008. Epub 2014 Feb 12. Clin Oncol (R Coll Radiol). 2014. PMID: 24529742

10

Prostate stereotactic body radiotherapy—first UK experience.

Tree AC, Ostler P, Hoskin P, Dankulchai P, Nariyangadu P, Hughes RJ, Wells E, Taylor H, Khoo VS, van As NJ. Tree AC, et al. Clin Oncol (R Coll Radiol). 2014 Dec;26(12):757-61. doi: 10.1016/j.clon.2014.08.007. Epub 2014 Sep 3. Clin Oncol (R Coll Radiol). 2014. PMID: 25193299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters